Fore Biotherapeutics

Philadelphia, United States

Fore Biotherapeutics is a precision oncology company specializing in cancer therapies guided by functional genomics.

$40.2M raised

May 2025

Series D

Biotechnology Health Care Health Diagnostics Medical Oncology

Top Investors

Wellington Management OrbiMed Cormorant Asset Management SR One Pontifax

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Fore Biotherapeutics

How much funding has Fore Biotherapeutics raised?

Fore Biotherapeutics has raised $40.2M in total funding. The most recent round was Series D. The last funding was announced in May 2025.

Who are Fore Biotherapeutics's investors?

Fore Biotherapeutics's investors include Wellington Management, OrbiMed, Cormorant Asset Management, SR One, Pontifax.

Where is Fore Biotherapeutics headquartered?

Fore Biotherapeutics is headquartered in Philadelphia, United States.

What does Fore Biotherapeutics do?

Fore Biotherapeutics is a precision oncology company specializing in cancer therapies guided by functional genomics.

What stage is Fore Biotherapeutics at?

Fore Biotherapeutics is at the Series D stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated May 6, 2025.

MLA

"Fore Biotherapeutics — Funding & Investors." VCBacked, May 6, 2025, https://www.vcbacked.co/company/fore-biotherapeutics. Accessed July 11, 2026.

APA

VCBacked. (2025). Fore Biotherapeutics — Funding & Investors. Retrieved July 11, 2026, from https://www.vcbacked.co/company/fore-biotherapeutics

Wikipedia (cite web)

{{cite web |title=Fore Biotherapeutics — Funding & Investors |url=https://www.vcbacked.co/company/fore-biotherapeutics |website=VCBacked |access-date=July 11, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated May 6, 2025.

Similar Companies in Biotechnology

View all

Allterum Therapeutics

Houston$1.0M

Renaissance BioScience

Advanced Microbiome Interventions

Amsterdam$300K